In order to analyze the robustness of the AD-Neuro model, we used it to analyze the effect of AD drugs, rivastigmine, donepezil and memantine wherein we could see a clear increase in ACh levels, expression of neuronal markers and cholinergic markers ChAT, α7nAChR, MAP2 and NEP. This evidence concerns the gene MME and Alzheimer disease.